Computed head-to-head · 6 dimensions
ABBV vs JNJ
AbbVie Inc. versus Johnson & Johnson — yield, safety, growth trend, cost, scale, and tax treatment.
ABBV wins 2–1 on our six-dimension comparison, but JNJ can still be the better fit depending on your priorities — see each dimension below.
Scorecard at a glance
| Dimension | ABBV | JNJ | Winner |
|---|---|---|---|
| Yield | 2.67% | 2.02% | ABBV wins |
| Dividend safety | 7.0/10 | 8.0/10 | JNJ wins |
| Growth trend | -0.93% vs 5y | -0.75% vs 5y | ABBV wins |
| Volatility (beta) | 0.28 | 0.23 | Tie |
| Scale | $453.9B | $616.5B | Tie |
| Tax efficiency | Qualified-eligible | Qualified-eligible | Tie |
| Overall | 2 wins | 1 wins | ABBV wins |
Dimension by dimension
ABBV wins on yield (2.67% vs 2.02%)
On a $10,000 investment that's about $65 more in annual dividend income before taxes — though higher yield often comes with higher risk.
ABBV's higher yield (2.67%) looks attractive but investors should weigh whether the extra income compensates for any additional risk versus JNJ's 2.02% — especially if the higher yield is driven by covered calls or a falling share price.
JNJ wins on safety (8.0/10 vs 7.0/10)
Our score combines yield zone, payout ratio, trend vs 5-year average, instrument type, and size. JNJ scores better on the weighted average of those factors.
JNJ (8.0/10) scores 1.0 points higher than ABBV (7.0/10). A higher safety score means lower historical indicators of dividend cut risk — payout ratio, yield zone, and trend all factor in.
ABBV shows healthier dividend-vs-price trend
ABBV's yield is 0.93% below its 5y average, versus 0.75% for JNJ. Lower (or below-average) yield trend often means price appreciation outpaced distributions — a healthier signal.
Volatility (beta) is similar
Both tickers move with comparable sensitivity to the broader market.
Comparable scale ($453.9B vs $616.5B)
Within 1.5x of each other on market cap / AUM — similar institutional footprint.
Both pay qualified-dividend-eligible distributions
Neither is structurally flagged for ordinary-income tax treatment. Most distributions should qualify for the lower long-term capital gains rate if holding-period requirements are met.
How we compare these
Every comparison on this page is computed from current public data, not written by hand. Yield comes from the most recent dividend distribution annualized over current price. Safety scores combine yield zone, payout ratio, trend vs 5-year average, instrument type, and size — see our methodology for the exact formula. Tax-efficiency flags identify covered-call ETFs, REITs, and mREITs which distribute primarily as ordinary income.
This is educational, not investment advice.Scores reflect a snapshot of public data on the "as of" dates shown on each ticker's safety page. Verify on the issuer's investor relations page or your brokerage before making decisions.
Frequently asked
Which is better for income, ABBV or JNJ?
ABBV wins 2–1 on our six-dimension comparison, but JNJ can still be the better fit depending on your priorities — see each dimension below.
ABBV vs JNJ: which has a higher dividend yield?
ABBV yields 2.67% and JNJ yields 2.02%. On a $10,000 investment that's about $65 more in annual dividend income before taxes — though higher yield often comes with higher risk.
Is ABBV or JNJ a safer dividend in 2026?
ABBV scores 7.0/10 (Solid) on the Infnits dividend safety scale. JNJ scores 8.0/10 (Strong). JNJ is the safer pick on our scoring model.
Which has better dividend growth, ABBV or JNJ?
ABBV's yield is 0.93% below its 5y average, versus 0.75% for JNJ. Lower (or below-average) yield trend often means price appreciation outpaced distributions — a healthier signal.
ABBV vs JNJ: which is more tax-efficient?
Neither is structurally flagged for ordinary-income tax treatment. Most distributions should qualify for the lower long-term capital gains rate if holding-period requirements are met.
Get emailed when ABBV vs JNJ data updates.
Already own ABBV or JNJ? See if the other adds anything.
Connect your brokerage and Infnits checks whether adding ABBV to your existing portfolio actually diversifies — or just duplicates exposure (ETF look-through included).
Check overlap with my portfolio →